What Longitudinal Studies Can Reveal About oGVHD

A clinical examination captures a patient’s condition at a particular moment. Ocular graft-versus-host disease, however, can change over time. Symptoms may emerge gradually. Tear production may decline. Ocular surface staining, eyelid changes, or conjunctival scarring may evolve. The degree of discomfort and the amount of supportive care required may also change. A single assessment cannot […]

From Biological Mechanism to Therapeutic Target

Understanding the biology of ocular graft-versus-host disease is an important step toward identifying potential therapeutic targets. But identifying a biological mechanism and demonstrating that it can be successfully targeted are different stages of scientific progress. In oGVHD, immune-mediated inflammation can affect multiple components of the ocular surface. Tear-producing glands, conjunctival tissue, corneal epithelium, eyelids, meibomian […]

Why Multidisciplinary Care Matters in oGVHD

Ocular graft-versus-host disease sits at the intersection of ophthalmology, transplant medicine, immunology, and chronic disease management. Following allogeneic hematopoietic cell transplantation, graft-versus-host disease can affect multiple organ systems. When the eyes are involved, patients may experience ocular surface inflammation, tear deficiency, epithelial damage, scarring, and other complications. Because the disease can affect different tissues and […]

Environmental Stress and an Already Vulnerable Ocular Surface

The ocular surface is continually exposed to the surrounding environment. Airflow, humidity, temperature, and other conditions can influence tear evaporation and ocular comfort. In a healthy eye, the tear film and protective reflexes help maintain a stable surface. In ocular graft-versus-host disease, those protective mechanisms may already be compromised. Reduced tear production can leave less […]

The Role of Imaging in Ocular Surface Research

Clinical examination remains central to evaluating ocular graft-versus-host disease, but imaging technologies may offer additional ways to study the structures involved. The ocular surface is a complex system. Its condition depends on tear production, epithelial integrity, eyelid function, gland activity, sensory nerves, and the interaction of these components. No single examination or measurement captures every […]

Preservatives, Formulations and the Compromised Ocular Surface

In ocular surface disease, treatment is not defined by its active ingredient alone. Formulation, frequency of use, and tolerability can also influence the overall experience of care. Eye drops and other topical products may contain active ingredients, preservatives, buffering agents, and other components that affect their properties. These formulation differences can be relevant when the […]

Why Treatment Burden Belongs in oGVHD Research

The impact of ocular graft-versus-host disease cannot always be captured by a clinical examination. For some patients, managing ocular surface disease may involve frequent lubrication, multiple topical products, specialized lenses, repeated appointments, and ongoing monitoring. The specific demands vary with disease severity and the individual’s care plan. These demands can affect daily routines. Treatments may […]

Inflammation and Fibrosis: Two Processes, Different Consequences

Inflammation and fibrosis are closely related processes, but they are not interchangeable. Inflammation is part of the immune response to injury or other biological threats. When inflammation persists or becomes dysregulated, it can contribute to ongoing tissue damage. Fibrosis involves the accumulation and remodeling of connective tissue, which can alter normal tissue structure and function. […]

The Ocular Surface Barrier: The Eye’s First Line of Defense

The ocular surface does more than keep the eye moist. It forms a protective interface between delicate eye tissues and the external environment. The corneal and conjunctival epithelium help protect underlying tissues while supporting the stable environment required for comfort and clear vision. The tear film, eyelids, mucin-producing cells, and local immune defenses contribute to […]

When Corneal Sensation Changes, Protection Can Change With It

Pain is one of the body’s warning systems. At the ocular surface, that warning system is especially sensitive because the cornea contains an exceptionally dense network of sensory nerves. When the surface becomes irritated or injured, those nerves help create the sensations that tell us something is wrong. But sensation is only part of their […]

Blinking Is Part of the Tear System

Blinking is so automatic that it is easy to think of it as separate from tear production. Biologically, the two are deeply connected. Each blink spreads the tear film across the cornea, redistributing fluid over a surface that would otherwise begin drying almost immediately. The movement of the eyelids also helps distribute lipids produced by […]

How the Eye Knows It Needs More Tears

Most people rarely think about tear production until they cry. But the tear system is working continuously, making small adjustments that help keep the ocular surface stable from one moment to the next. Those adjustments begin with sensation. Corneal nerves monitor the environment at the front of the eye. As tears evaporate between blinks, the […]

The Trigeminal Nerve: A Communication Pathway for the Ocular Surface

Tear production begins with a gland, but the decision to produce tears is partly a neurological event. To understand why, it helps to follow the path of a signal. The cornea is densely supplied with sensory nerve endings that continually monitor conditions at the ocular surface. When those nerves detect changes such as evaporation, cooling, […]

From the Ocular Surface to the Brain: The Sensory System Behind the Eye

The ocular surface is exposed to the outside world every moment the eyes are open. Wind, temperature, evaporation, airborne particles, light, and the mechanical movement of the eyelids all create potential sources of stress. Yet most of the time, we are barely aware of any of them. That apparent quiet depends on an extraordinarily sensitive […]

oGVHD Does Not Follow a Simple Post-Transplant Timeline

Patients recovering from an allogeneic hematopoietic stem cell transplant become accustomed to milestones. Days, weeks, and months after transplantation carry meaning. Laboratory values are tracked. Medications change. Infection risks evolve. Follow-up schedules shift. It would be convenient if ocular GVHD followed an equally predictable timetable. It does not. Chronic oGVHD often emerges after the immediate […]

Why the Best Time to Understand the Eyes May Be Before Transplant

When ocular symptoms appear after an allogeneic hematopoietic stem cell transplant, one of the first questions is often whether something has changed. That question is much easier to answer when clinicians know where the patient started. A pre-transplant ophthalmic evaluation can establish a baseline picture of the ocular surface before the immune and systemic changes […]

The NIH Eye Score: Measuring More Than What the Eye Looks Like

How do you measure the severity of a disease when the clinical examination tells only part of the story? That problem has shaped the way ocular graft-versus-host disease is assessed. In chronic GVHD, the National Institutes of Health developed an organ scoring system that includes the eyes. The ocular score ranges from no symptoms to […]

Tear-Film Stability: Why Making Tears Is Only Part of the Job

When we think about dry eye, it is natural to focus on quantity. Does the eye produce enough tears? That question matters, particularly in oGVHD, where lacrimal gland damage can cause profound aqueous tear deficiency. But the amount of fluid present is only one part of normal tear function. The tear film must also remain […]

What Corneal Staining Reveals About an Eye Under Stress

The cornea is transparent by design. That is essential for vision, but it can make early surface damage difficult to appreciate with the naked eye. Ocular surface staining gives clinicians a way to make some of that damage visible. During an eye examination, a diagnostic dye such as fluorescein can be applied to the ocular […]

What the Schirmer Test Can Tell Us About oGVHD, and What It Cannot

During a Schirmer test, a small strip of filter paper is placed inside the lower eyelid. As tears wet the paper, clinicians can measure how far the moisture travels over a set period of time. The result provides an estimate of aqueous tear production. In oGVHD, that information can be important because the lacrimal glands […]

How oGVHD Is Diagnosed: Building the Clinical Picture

Ocular graft-versus-host disease can be difficult to diagnose for the same reason it can be difficult to live with: it does not present in exactly the same way in every patient. One person may develop profound tear deficiency after allogeneic hematopoietic stem cell transplantation. Another may have more prominent inflammation, corneal staining, eyelid disease, or […]

What Scleral Lenses Teach Us About Ocular Surface Protection

Scleral lenses are not a cure for oGVHD, but they teach an important lesson about ocular surface protection. Unlike standard contact lenses, scleral lenses vault over the cornea and rest on the sclera, the white part of the eye. This design can create a fluid reservoir over the corneal surface. In patients with severe ocular […]

The Challenge of Measuring Treatment Response in oGVHD Trials

Clinical trials in oGVHD face a difficult question: what does improvement mean? In some diseases, a single laboratory value or imaging finding can define response. oGVHD is more complex. It can involve symptoms, ocular surface staining, tear production, tear stability, conjunctival disease, corneal epithelial integrity, eyelid changes, meibomian gland function, inflammation, fibrosis, and quality of […]

oGVHD as a Transplant Survivorship Issue

Allogeneic hematopoietic cell transplantation can be life-saving. But survivorship can bring long-term complications, including chronic graft-versus-host disease. For many patients, the eyes become part of that survivorship story. oGVHD can affect comfort, vision, independence, and daily function. Patients may struggle with reading, computer work, driving, light exposure, outdoor activities, sleep, or simply keeping the eyes […]

The Role of Biomarkers in Understanding oGVHD

oGVHD remains difficult to diagnose, stage, and monitor. Biomarkers may help move the field toward greater precision. A biomarker is a measurable biological signal that provides information about disease activity, risk, progression, or treatment response. In oGVHD, researchers have studied molecular signals in tears, cytokines, proteomic markers, lipid mediators, leukocyte-related markers, genetic and molecular signatures, […]

Why Symptoms and Clinical Signs Often Diverge in oGVHD

One of the most challenging features of oGVHD is the mismatch between symptoms and clinical signs. Some patients report severe pain, dryness, burning, grittiness, or light sensitivity even when visible findings appear moderate. Others may show clear ocular surface damage but report fewer symptoms than expected. This divergence can be confusing for patients, clinicians, and […]

Meibomian Gland Dysfunction in the Context of oGVHD

The meibomian glands are small glands in the eyelids, but their role in ocular surface health is significant. They secrete lipids that help stabilize the tear film and reduce evaporation. Meibomian gland dysfunction is often discussed in routine dry eye disease. In oGVHD, it should be understood in a broader disease context. The glands may […]

Corneal Epithelial Damage in oGVHD

The cornea is the transparent front surface of the eye. Its outer layer, the corneal epithelium, protects the eye, supports clear vision, and contributes to comfort. In oGVHD, this surface can become fragile. Corneal epithelial damage may develop when several protective systems fail at once. Tear production may decline. Tear-film quality may deteriorate. Blinking may […]

How Conjunctival Inflammation and Fibrosis Shape oGVHD

The conjunctiva is easy to overlook, but in oGVHD it can be central to disease progression. The conjunctiva is the membrane that lines the inside of the eyelids and covers part of the white surface of the eye. It helps maintain ocular surface health, supports immune defense, and contributes to tear-film stability. Conjunctival goblet cells […]

The Lacrimal Functional Unit and Why It Matters in oGVHD

The eye maintains comfort and clarity through a coordinated biological system. One useful way to understand this system is the lacrimal functional unit. The lacrimal functional unit includes the lacrimal glands, ocular surface, eyelids, meibomian glands, conjunctival goblet cells, sensory nerves, and neural reflex pathways that help regulate tearing and blinking. These structures work together […]

The Immunology of Ocular GVHD

Ocular GVHD (oGVHD) begins with transplant immunology, but its effects can become intensely local. After allogeneic hematopoietic stem cell transplantation, the donor immune system may recognize recipient tissues as foreign. In chronic graft-versus-host disease, immune-mediated inflammation and fibrosis can affect multiple organs, including the skin, mouth, gastrointestinal tract, liver, lungs, fascia, genital tract, and eyes. […]

Why oGVHD Is More Than Dry Eye

Ocular graft-versus-host disease, often abbreviated as oGVHD, is sometimes described as a severe form of dry eye. That shorthand is understandable, but it is incomplete. Dry eye is one of the most visible ways oGVHD is experienced by patients. Burning, grittiness, dryness, light sensitivity, foreign body sensation, tearing, and fluctuating vision are common complaints. But […]

Why the Tear Film Matters More Than Most People Realize

Most people think of tears as something that appears when we cry. In ocular health, tears are much more than water. They are a living, protective system that supports comfort, vision, and the health of the ocular surface. The tear film coats the front of the eye every time we blink. It helps keep the […]

Understanding Ocular Graft-Versus-Host Disease: Pathophysiology and Clinical Implications

At Signal12 Inc., we are committed to advancing knowledge about complex medical conditions that impact quality of life, such as ocular graft-versus-host disease (oGVHD). This condition, a significant complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT), affects approximately 40-60% of transplant recipients, manifesting as a debilitating ocular surface disorder. oGVHD arises when donor immune cells […]

Diagnostic Challenges in Ocular Graft-Versus-Host Disease: Current Tools and Future Directions

Ocular graft-versus-host disease (oGVHD) is a frequent and debilitating complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), affecting up to 60% of recipients. Accurate diagnosis is critical to initiate timely treatment and prevent irreversible ocular damage, yet the condition’s heterogeneity and overlap with other ocular surface diseases pose significant challenges. Current diagnostic tools, rooted in […]

Therapeutic Advances in Managing Ocular GVHD: From Topical Treatments to Surgical Interventions

Ocular graft-versus-host disease (oGVHD) transforms the eyes into battlegrounds of immune dysregulation post-allo-HSCT, necessitating robust therapeutic strategies. From topical agents to surgical interventions, management has evolved significantly, yet no single approach universally halts progression. This post surveys the therapeutic landscape, emphasizing evidence-based options and cutting-edge developments as of 2025. Topical Treatments First-line therapy targets inflammation […]

Join Our Mission

Signal12 is planning to facilitate Phase 3 clinical trials in 2026 and bring Pro-ocular™ to market.

Contact Us Today